Hillsdale Investment Management Inc. Harvard Bioscience Inc Transaction History

Hillsdale Investment Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.02 - $5.39 $106,127 - $142,296	26,400 New	26,400 $111,000
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $100,182 - $147,285	23,910 New	23,910 $131,000
Q4 2021 Feb 07, 2022	SELL	$6.37 - $8.18 $2.57 Million - $3.3 Million	-403,291 Closed	0 $0
Q3 2021 Oct 21, 2021	SELL	$6.98 - $8.47 $536,406 - $650,911	-76,849 Reduced 16.01%	403,291 $2.82 Million
Q2 2021 Jul 29, 2021	BUY	$5.44 - $8.4 $418,058 - $645,531	76,849 Added 19.06%	480,140 $4 Million
Q4 2020 Feb 09, 2021	SELL	$3.0 - $4.5 $3,900 - $5,850	-1,300 Reduced 0.32%	403,291 $1.73 Million
Q3 2020 Nov 13, 2020	SELL	$2.75 - $4.2 $22,825 - $34,860	-8,300 Reduced 2.01%	404,591 $1.22 Million
Q2 2020 Aug 11, 2020	BUY	$2.12 - $3.14 $875,328 - $1.3 Million	412,891 New	412,891 $1.28 Million
Q4 2018 Feb 12, 2019	SELL	$3.03 - $5.0 $9,696 - $16,000	-3,200 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$5.0 - $6.65 $16,000 - $21,280	3,200 New	3,200 $17,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.